Guardant Health (GH) Income from Continuing Operations (2017 - 2026)
Guardant Health's (GH) quarterly Income from Continuing Operations came in at -$120.1 million in Q2 2026, down 20.26% year-over-year from -$150.7 million in Q2 2025, and down 7.2% quarter-over-quarter from -$112.1 million in Q1 2026.
Analysis
Guardant Health (GH) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Guardant Health has disclosed Income from Continuing Operations across 10 years of filings, most recently posting -$120.1 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations fell 20.26% year-over-year to -$120.1 million; the TTM figure through Jun 2026 stood at -$453.4 million (down 9.57% YoY), while the FY2025 annual figure was -$416.3 million, up 4.61% from the prior year.
- Income from Continuing Operations came in at -$120.1 million for Q2 2026 at Guardant Health, down from -$112.1 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of -$72.8 million in Q2 2023 to a low of -$229.4 million in Q2 2022.
- Average Income from Continuing Operations over 5 years is -$123.3 million, with a median of -$113.5 million recorded in 2024.
- Year-over-year, Income from Continuing Operations slumped 135.13% in 2022 and soared 68.28% in 2023.
- Over 5 years, Income from Continuing Operations stood at -$139.9 million in 2022, then plunged by 33.67% to -$187.0 million in 2023, then surged by 40.65% to -$111.0 million in 2024, then dropped by 15.75% to -$128.5 million in 2025, then increased by 6.5% to -$120.1 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$120.1 million in Q2 2026, -$112.1 million in Q1 2026, and -$128.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -66.93 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 324.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 8.51 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -637,000.00 |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -16.21 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -381,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -120.14 Mn |
| Mar 31, 2026 | -112.08 Mn |
| Dec 31, 2025 | -128.49 Mn |
| Sep 30, 2025 | -92.73 Mn |
| Jun 30, 2025 | -99.90 Mn |
| Mar 31, 2025 | -95.16 Mn |
| Dec 31, 2024 | -111.01 Mn |
| Sep 30, 2024 | -107.75 Mn |
| Jun 30, 2024 | -102.63 Mn |
| Mar 31, 2024 | -114.99 Mn |
| Dec 31, 2023 | -187.04 Mn |
| Sep 30, 2023 | -86.10 Mn |
| Jun 30, 2023 | -72.77 Mn |
| Mar 31, 2023 | -133.53 Mn |
| Dec 31, 2022 | -139.93 Mn |
| Sep 30, 2022 | -161.99 Mn |
| Jun 30, 2022 | -229.43 Mn |
| Mar 31, 2022 | -123.23 Mn |
| Dec 31, 2021 | -72.31 Mn |
| Sep 30, 2021 | -107.53 Mn |